Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30.
Pelser C, Middeldorp J, Mbulaiteye SM, Lauria C, Messina A, Viviano E, Romano N, Vitale F, Goedert JJ. Infect Agent Cancer. 2010 Oct 12; 5:18. Epub 2010 Oct 12.